02 Jun The Future Of Clinical Trials Is Neurodiverse

By Brianna T. Polite, Clinical Leader

Clinical research has a talent problem, and the future of this industry depends on how we respond. It’s not just about recruitment or retention. It’s about the voices we’re not hearing. And yet, despite the growing conversation around equity, one dimension remains under-addressed: cognitive diversity. It’s about the voices we’re not hearing, the minds we’re not cultivating, and the systems we’re not questioning.

As someone with AuADHD (autism and ADHD) who has spent years monitoring global trials, I’ve seen how neurodivergent professionals often work twice as hard to mask their differences, while offering insights that, if embraced, could improve protocol compliance, reduce delays, and elevate participant experience.

So why is neurodiversity still missing from clinical trial strategy? Read more…